Second Sight Medical Products Inc
Change company Symbol lookup
Select an option...
EYES Second Sight Medical Products Inc
BORR Borr Drilling Ltd
AMZN Amazon.com Inc
GOOGL Alphabet Inc
TRBCX T. Rowe Price Blue Chip Growth Fund
KR Kroger Co
PM Philip Morris International Inc
MO Altria Group Inc
KMB Kimberly-Clark Corp
JNJ Johnson & Johnson
Go

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Company intends to develop Orion Visual Cortical Prosthesis which provides useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease or forms of cancer and trauma. Its product, The Argus II Retinal Prosthesis System (The Argus II) provides electrical stimulation of the retina to induce visual perception in blind individuals and helps in treating outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight. The Company's Argus II System employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals.

Price
Delayed
$4.26
Day's Change
-0.01 (-0.23%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.28
Day's Low
3.93
Volume
(Heavy Day)

Today's volume of 47,983 shares is on pace to be much greater than EYES's 10-day average volume of 44,989 shares.

47,983

Upcoming Events

EYES's fiscal year ends in December
There are no upcoming events for EYES

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
November 14, 2019Q3 2019 Earnings Release-$0.48-$0.06 to -$0.06-$0.96
August 6, 2019Q2 2019 Earnings Release-$0.56-$0.06 to -$0.06-$0.96
May 15, 2019Q1 2019 Earnings Release-$0.80-$0.06 to -$0.06--
March 13, 2019Q4 2018 Earnings Release-$0.96-$0.11 to -$0.11--

Past Stock Splits

DateEvent description
January 6, 20201:8 Stock Split

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.